PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424475
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1424475
Global mycoplasma testing market size is expected to reach US$ 1,907.6 Mn by 2031, from US$ 997.8 Mn in 2024, exhibiting a compound annual growth rate (CAGR) of 9.7% during the forecast period.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2023/2024: | US$ 997.8 Mn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024-2031 |
Forecast Period 2023/2024 to 2030/2031 CAGR: | 9.70% | 2030/2031 Value Projection: | US$ 1,907.6 Mn |
Mycoplasma testing is essential in the field of biotechnology and pharmaceuticals. There are different types of products available in the market for mycoplasma testing. The major products can be categorized into two types - kits and services.
Kits are self-contained tools that allow researchers to test for mycoplasma contamination on their own. These kits have all the necessary reagents and instructions to perform the test. The most common types of kits are polymerase chain reaction (PCR)-based kits, enzyme-linked immunosorbent assay (ELISA) based kits, and microbiological-based kits. PCR kits are highly sensitive and specific but require specialized equipment. ELISA kits are easier to use as they don't need specialized equipment but are less sensitive than PCR. Microbiological kits involve detecting mycoplasma growth directly but take longer time to give results.
Along with kits, various companies offer mycoplasma testing as services where researchers can send their samples to specialized testing facilities. The advantage of services is that researchers do not need to invest in equipment or training. Experienced technicians at the service facilities perform different types of tests like PCR, ELISA, and microbiological assays and provide reports. However, there can be delays in getting results as samples need to be shipped. Kits allow for faster testing but require proper infrastructure. Both products have their advantages in different situations depending on individual lab requirements and capacities.
Growing research and development (R&D) activities by the market players is expected drive the market growth over the forecast period. Moreover, increasing organic and inorganic strategies by the market players will aid in the market growth over the forecast period.